ABBV · Healthcare
Abbvie Inc
33/100
Smart-money confidence1 of 3 sources positive
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
44
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$439.7B
Industry
Drug Manufacturers - General
Sector
Healthcare
Exchange
NYSE
About ABBVIE INC
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products;…
Who's behind the signal
Every informed buyer we can see on ABBV, across all three feeds.
Hedge funds · 8
Tudor Investment (Paul Tudor Jones)
Increased +42%
Millennium Management (Englander)
Increased +3297%
Gotham Asset Mgmt (Greenblatt)
Increased +15%
Bridgewater Associates (Dalio)
Increased +114%
Polen Capital Management
Unchanged
D.E. Shaw & Co
Unchanged
+2 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 48 on record
Disclosures from 2014-03-31 to 2022-08-05
The newest disclosure we hold for this stock is 2022-08-05.
That is the end of our data, not necessarily the end of the trading — our
bulk STOCK Act archive stops there and newer filings arrive through a
separate live feed. Treat the absence of recent rows as “not covered”,
not as “no trades”.
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2022-08-05 | Dwight Evans · D-PA | House | Bought | $1,001 - $15,000 |
| 2022-06-16 | Robert J. Wittman · R-VA | House | Bought | $1,001 - $15,000 |
| 2022-03-17 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2022-03-08 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2022-02-18 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2022-02-09 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2022-01-28 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2021-12-13 | Adam B. Schiff · D-CA | House | Sold | $15,001 - $50,000 |
| 2021-11-26 | Bob Gibbs · R-OH | House | Bought | $1,001 - $15,000 |
| 2021-08-09 | Zoe Lofgren · D-CA | House | Bought | $1,001 - $15,000 |
Show the other 38
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2021-07-23 | Adam B. Schiff · D-CA | House | Sold | $1,001 - $15,000 |
| 2021-06-18 | Debbie Dingell · D-MI | House | Sold | $50,001 - $100,000 |
| 2021-06-16 | Marjorie Taylor Greene · R-GA | House | Bought | $1,001 - $15,000 |
| 2021-04-30 | Kathy E. Manning · D-NC | House | Sold | $1,001 - $15,000 |
| 2021-02-16 | Peter Meijer · R-MI | House | Sold | $1,001 - $15,000 |
| 2021-02-11 | Ro Khanna · D-CA | House | Bought | $1,001 - $15,000 |
| 2020-12-22 | Gilbert Ray Cisneros, Jr. · D-CA | House | Bought | $1,001 - $15,000 |
| 2020-11-20 | Thomas R. Carper · D-DE | Senate | Bought | $1,001 - $15,000 |
| 2020-11-20 | Joseph D. Morelle · D-NY | House | Sold | $1,001 - $15,000 |
| 2020-11-19 | Kenny Marchant · R-TX | House | Bought | $15,001 - $50,000 |
| 2020-11-17 | Bob Gibbs · R-OH | House | Bought | $15,001 - $50,000 |
| 2020-11-17 | Kenny Marchant · R-TX | House | Sold | $15,001 - $50,000 |
| 2020-10-13 | Debbie Dingell · D-MI | House | Bought | $15,001 - $50,000 |
| 2020-08-21 | Jerry Moran · R-KS | Senate | Sold | $1,001 - $15,000 |
| 2020-07-09 | Thomas R. Carper · D-DE | Senate | Sold | $1,001 - $15,000 |
| 2020-06-29 | William R. Timmons IV · R-SC | House | Sold | $1,001 - $15,000 |
| 2020-05-08 | Steve Chabot · R-OH | House | Bought | $1,001 - $15,000 |
| 2020-04-14 | David Perdue · R-GA | Senate | Sold | $15,001 - $50,000 |
| 2020-04-14 | Kelly Loeffler · R-GA | Senate | Sold | $250,001 - $500,000 |
| 2020-04-07 | Kelly Loeffler · R-GA | Senate | Bought | $15,001 - $50,000 |
| 2020-04-07 | Kelly Loeffler · R-GA | Senate | Bought | $1,001 - $15,000 |
| 2020-03-24 | Thomas R. Carper · D-DE | Senate | Bought | $1,001 - $15,000 |
| 2020-02-27 | Robert J. Wittman · R-VA | House | Bought | $1,001 - $15,000 |
| 2020-02-20 | Kelly Loeffler · R-GA | Senate | Sold | $1,001 - $15,000 |
| 2020-01-07 | Kurt Schrader · D-OR | House | Sold | $1,001 - $15,000 |
| 2019-12-11 | Daniel Meuser · R-PA | House | Sold | $1,001 - $15,000 |
| 2019-07-15 | David Perdue · R-GA | Senate | Sold | $15,001 - $50,000 |
| 2019-07-02 | Carol D. Miller · R-WV | House | Bought | $15,001 - $50,000 |
| 2018-12-06 | Jerry Moran · R-KS | Senate | Bought | $1,001 - $15,000 |
| 2017-01-20 | John Hoeven · R-ND | Senate | Sold | $100,001 - $250,000 |
| 2015-09-10 | Gary C. Peters · D-MI | Senate | Bought | $1,001 - $15,000 |
| 2015-03-10 | Sheldon Whitehouse · D-RI | Senate | Sold | $1,001 - $15,000 |
| 2015-02-25 | John Hoeven · R-ND | Senate | Bought | $100,001 - $250,000 |
| 2015-02-12 | Thomas R. Carper · D-DE | Senate | Bought | $1,001 - $15,000 |
| 2014-12-18 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2014-09-29 | John Hoeven · R-ND | Senate | Sold | $100,001 - $250,000 |
| 2014-04-28 | John Hoeven · R-ND | Senate | Bought | $50,001 - $100,000 |
| 2014-03-31 | John Hoeven · R-ND | Senate | Bought | $50,001 - $100,000 |
Not a model pick — but on our radar.
ABBVIE INC isn't in the top-10 model right now, but 8 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
8
Investors
0
New positions
4
Increasing
2
Decreasing
2
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.2×
% of portfolio
0.2%
Position change
+42%
0.2% of Tudor Investment's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+3297%
0.1% of Millennium Management's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
+15%
0.1% of Gotham Asset Mgmt's portfolio
Trust weight: 1.3×
% of portfolio
0.0%
Position change
+114%
0.0% of Bridgewater Associates's portfolio
Trust weight: 1.3×
% of portfolio
0.2%
Position change
—
0.2% of Polen Capital Management's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
—
0.1% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
−23%
0.1% of AQR Capital Management's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
−33%
0.1% of Citadel Advisors's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to ABBVIE INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell ABBVIE INC or any security.
订阅每周更新
我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费，直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订